furosemide has been researched along with natriuretic peptide, brain in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.17) | 18.2507 |
| 2000's | 18 (28.57) | 29.6817 |
| 2010's | 36 (57.14) | 24.3611 |
| 2020's | 7 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P; Arroyo, V; Brenner, BM; Guo, J; Jiménez, W; Mackenzie, HS; Ros, J; Troy, JL; Zhang, PL | 1 |
| Barron, J; Buckley, MG; Grouzmann, E; MacGregor, GA; Missouris, CG; Singer, DR | 1 |
| Espiner, EA; Frampton, CM; Nicholls, MG; Richards, AM; Troughton, RW; Yandle, TG | 1 |
| Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
| Orda, A; Przewłocka-Kosmala, M; Salomon, P | 1 |
| Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Costello-Boerrigter, LC; Heublein, DM; Malatino, LS; Schirger, JA; Tsuruda, T | 1 |
| Graham, CA | 1 |
| Gregory, A; Mowdy, MH; Sharp, RP; Sirajuddin, R | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Di Gaudio, F; Di Pasquale, P; Fasullo, S; Fornaciari, E; Giammanco, M; Licata, G; Parrinello, G; Paterna, S; Sarullo, FM | 1 |
| Bech, JN; Jensen, P; Nyvad, O; Pedersen, EB; Starklint, J | 1 |
| Atar, D; Hodt, A; Steine, K | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Azzetti, G; Carlucci, S; Cioffi, G; Furlanello, F; Marco, R; Stefenelli, C; Tarantini, L | 1 |
| Kurien, S; Miller, WL; Warfield, KT; Wood, CM | 1 |
| Campana, C; Cosmai, L; Dal Canton, A; Libetta, C; Meloni, F; Monti, C; Pisacco, P; Rampino, T; Sepe, V; Tavazzi, L; Zucchi, M | 1 |
| Di Pasquale, P; Fasullo, S; Gaspare, P; Paterna, S; Sarullo, FM | 1 |
| Adams, KF; Califf, RM; Gattis Stough, W; Hasselblad, V; Lokhnygina, Y; O'Connor, CM; Shah, MR | 1 |
| Karajala, V; Kellum, JA; Mansour, W | 1 |
| Goebel, JA; Van Bakel, AB | 1 |
| Nakano, H; Nakayama, M | 1 |
| Hayashi, T; Hosoda, K; Matsuo, M; Miyazaki, A; Sakaguchi, H; Tsuda, E | 1 |
| Ahmadi, R; Berger, R; Huelsmann, M; Moertl, D; Pacher, R; Peter, S; Wagner, B; Yamuti, S | 1 |
| Caruso, C; Corrao, S; Di Raimondo, D; Di Sciacca, R; Licata, G; Pinto, A; Scaglione, R; Tuttolomondo, A | 1 |
| Flønaes, B; Grundtvig, M; Gullestad, L; Hole, T; Westheim, A | 1 |
| Gottwald, MD; Mills, RM; Oren, RM; Sica, D | 1 |
| Bonfils, PK; Damgaard, M; Gadsbøll, N; Goetze, JP; Norsk, P; Taskiran, M | 1 |
| Feola, M; Lombardo, E; Piccolo, S; Taglieri, C; Vallauri, P; Valle, R | 1 |
| Collinson, PO; Damman, K; Gaze, D; Hillege, HL; Lip, GY; MacFadyen, RJ; Ng Kam Chuen, MJ; van Oeveren, W; van Veldhuisen, DJ; Voors, AA | 1 |
| Hanawa, H; Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oda, M; Wada, Y | 1 |
| Furusho, Y; Hamasaki, S; Ikeda, Y; Kubozono, T; Kusumoto, A; Miyata, M; Sasaki, T; Shinsato, T; Tei, C | 1 |
| Pan, X; Yu, X; Zhang, J; Zhao, G | 1 |
| Gerlach, N; Klima, A; Weber, K; Wess, G; Wolf, J | 1 |
| Branzi, G; Della Rosa, F; Facchini, M; Malfatto, G; Parati, G; Rella, V; Villani, A | 1 |
| Cardillo, M; Di Pasquale, P; Giambanco, S; Iatrino, R; Lupo, U; Montaina, C; Parrinello, G; Paterna, S; Petrantoni, R; Schimmenti, C; Torres, D | 1 |
| Azoulay, E; Beduneau, G; Brochard, L; Cabello, B; Castanares-Zapatero, D; Devaquet, J; Jaber, S; Katsahian, S; Kouatchet, A; Lellouche, F; Mekontso Dessap, A; Roche-Campo, F; Sonneville, R; Tomicic, V | 1 |
| Agvall, B; Alehagen, U; Dahlström, U | 1 |
| Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M | 1 |
| Braunwald, E; Felker, GM; Givertz, MM; McNulty, S; O'Connor, CM; Shah, RV | 1 |
| Braunwald, E; Felker, GM; Hernandez, AF; Kociol, RD; Lee, KL; McNulty, SE; O'Connor, CM; Redfield, MM; Tracy, RP | 1 |
| Chen, B; Cheng, X; Hong, K; Hu, W; Li, Y; Peng, Q; Su, H; Wu, Y | 1 |
| Bartone, C; Chung, ES; Egnaczyk, GF; Jefferies, JL; Menon, S; O'Brien, TM | 1 |
| Almeida, S; Bettencourt, P; Carvalho, H; Ferreira, JP; Marques, I; Santos, M | 2 |
| Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K | 1 |
| Agostoni, P; Borghi, C; Cosentino, ER; Donghi, V; Ferramosca, E; Marenzi, G; Milazzo, V; Muratori, M; Rinaldi, ER; Santoro, A | 1 |
| Dupont, M; Mullens, W; Shrestha, K; Singh, D; Tang, WH; Testani, JM; Verbrugge, FH | 1 |
| Campagna, MS; Franci, B; Gilleman, M; Martini, G; McCullough, PA; Nuti, R; Palazzuoli, A; Pellegrini, M; Ronco, C; Ruocco, G | 1 |
| Aksu, NM; Arici, M; Ascioglu, S; Soyler, C; Tanriover, MD | 1 |
| Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K | 1 |
| Budaj, A; Imiela, T | 1 |
| Bouvier, P; Cerboni, P; Chiche, O; Doyen, D; Ferrari, E; Moceri, P; Schouver, ED | 1 |
| Beck-da-Silva, L; Bertoldi, EG; Biolo, A; da Rosa, PR; Danzmann, LC; Doebber, M; Figueiredo Neto, JA; Kohler, I; Moura, LZ; Prado, DP; Ribeiro, ALP; Rohde, LE; Rover, M; Sant'Anna, RT; Simões, MV | 1 |
| Ariotti, S; Cardone, M; Feola, M; Ferreri, C; Rosso, GL; Sola, M; Testa, M | 1 |
| Beijerink, NJ; Kooistra, HS; Yata, M | 1 |
| Banasiak, W; Biegus, J; Halpert, A; Levin, H; Ponikowski, P; Siwolowski, P; Szachniewicz, J; Testani, J; Tycińska, A; Zymlinski, R | 1 |
| Bergerone, S; Boretto, P; Canavosio, FG; De Ferrari, GM; Frea, S; Galluzzo, A; Golzio, PG; Pidello, S; Volpe, A | 1 |
| Ammar, H; Govindu, R; Sallam, T; Stingo, FE | 1 |
| Afsar, B; Copur, S; Covic, A; Kanbay, M; Nistor, I; Siriopol, D; Tapoi, L; Ureche, C | 1 |
| Felker, GM; Fudim, M; Hernandez, AF; Kittipibul, V; Mentz, RJ; O'Connor, CM; Spates, T; Starling, RC; Sun, JL; Tang, WHW; Testani, JM | 1 |
| Alhan, A; Altay, H; Altın, C; Ataş, AE; Baş, MM; Çakmak, HA; Demirkan, B; Dereli, S; Durakoğlugil, ME; Ekici, B; Fahri Erkan, A; Karavelioğlu, Y; Kılıçaslan, B; Kılıçaslan, F; Kıvrak, T; Küçük, M; Olgun, FE; Özkan, H; Şabanoğlu, C; Tengiz, İ; Yaman, M; Yenerçağ, M; Yiğit, Z; Zoghi, M | 1 |
| Asarisi, F; Berkane, N; Breittmayer, JP; Bun, S; Doyen, D; Ferrari, E; Fourrier, E; Heme, N; Labbaoui, M; Moceri, P; Redjimi, N; Sartre, B; Squara, F | 1 |
| Jian, X; Kan, B; Li, Y; Shi, L; Wang, W; Wen, Z; Yu, G; Zhao, L | 1 |
5 review(s) available for furosemide and natriuretic peptide, brain
| Article | Year |
|---|---|
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Critical Illness; Developed Countries; Diuretics; Emergency Service, Hospital; Emergency Treatment; Evidence-Based Medicine; Furosemide; Heart Failure; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Oxygen Inhalation Therapy; Patient Selection; Pulmonary Edema; Pyridazines; Pyridines; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2004 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
Diuretics in acute kidney injury.
Topics: Acute Kidney Injury; Animals; Cohort Studies; Combined Modality Therapy; Contraindications; Critical Care; Disease Models, Animal; Diuretics; Diuretics, Osmotic; Dopamine; Fluid Therapy; Furosemide; Humans; Length of Stay; Mannitol; Meta-Analysis as Topic; Natriuretic Peptide, Brain; Pulmonary Edema; Randomized Controlled Trials as Topic; Renal Dialysis; Rhabdomyolysis; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2009 |
Rational use of diuretics in acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Diuretics; Drug Resistance; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Natriuresis; Natriuretic Agents; Natriuretic Peptide, Brain; Nitrates; Purinergic P1 Receptor Antagonists; Sodium Chloride Symporter Inhibitors; Syndrome; Ultrafiltration; Vasoconstriction | 2008 |
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Body Weight; Diuresis; Diuretics; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidney Function Tests; Length of Stay; Natriuretic Peptide, Brain; Observational Studies as Topic; Patient Readmission; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic; Weight Loss | 2021 |
28 trial(s) available for furosemide and natriuretic peptide, brain
| Article | Year |
|---|---|
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Digoxin; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left | 2000 |
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Topics: Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electric Impedance; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Saline Solution, Hypertonic; Time Factors | 2005 |
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cross-Over Studies; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Renin | 2006 |
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Stroke Volume; Sulfonamides; Tomography, Emission-Computed, Single-Photon; Torsemide; Ventricular Remodeling | 2006 |
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
Topics: Aged; Aged, 80 and over; Aldosterone; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Renin; Sodium, Dietary; Survival Analysis; Treatment Outcome | 2008 |
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
Topics: Aged; Cardiotonic Agents; Databases as Topic; Female; Furosemide; Heart Failure; Hospitalization; Humans; Kidney; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome; Weight Loss | 2007 |
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Austria; Cardiology; Diuretics; Female; Furosemide; Heart Failure; Home Care Services, Hospital-Based; Humans; Length of Stay; Male; Natriuretic Peptide, Brain; Office Visits; Patient Readmission; Peptide Fragments; Pilot Projects; Primary Health Care; Prospective Studies; Referral and Consultation; Risk Assessment; Specialties, Nursing; Spironolactone | 2010 |
Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cross-Over Studies; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Natriuresis; Natriuretic Agents; Natriuretic Peptide, Brain; Sodium Potassium Chloride Symporter Inhibitors; Systole; Time Factors; Treatment Outcome; United States; Ventricular Dysfunction; Ventricular Function | 2010 |
Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
Topics: Aged; Cardiac Output; Case-Control Studies; Echocardiography; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Natriuretic Peptide, Brain; Pyridazines; Simendan; Time Factors | 2011 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardiography; Female; Furosemide; Heart Failure; Heart Function Tests; Humans; Male; Natriuretic Peptide, Brain; Outpatients; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2012 |
Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Aminophylline; Bronchodilator Agents; Disease Progression; Drug Combinations; Female; Furosemide; Glucocorticoids; Health Status; Health Status Indicators; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Pulmonary Disease, Chronic Obstructive; Quality of Life; Vasodilator Agents | 2012 |
Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
Topics: Aged; Calcium; Chronic Disease; Data Interpretation, Statistical; Diuretics; Drug Administration Schedule; Female; Furosemide; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Mortality; Natriuretic Peptide, Brain; Pyridazines; Severity of Illness Index; Simendan; Treatment Outcome; Ventricular Function | 2012 |
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler, Color; Electric Impedance; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Potassium; Saline Solution, Hypertonic; Troponin I | 2012 |
Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial.
Topics: Acetazolamide; Aged; Diuretics; Female; Furosemide; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome; Ventilator Weaning; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 2012 |
The benefits of using a heart failure management programme in Swedish primary healthcare.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Disease Management; Diuretics; Female; Follow-Up Studies; Furosemide; General Practice; Guideline Adherence; Heart Failure, Systolic; Humans; Male; Natriuretic Peptide, Brain; Nurse Clinicians; Patient Care Team; Patient Education as Topic; Patient Readmission; Peptide Fragments; Primary Health Care; Prospective Studies; Stroke Volume; Sweden | 2013 |
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Creatinine; Cystatin C; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Outpatients; Pain Measurement; Patient Readmission; Peptide Fragments; Proportional Hazards Models; Treatment Outcome | 2012 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Research Design; Tolvaptan | 2014 |
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Diuretics; Edema; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Peptide Fragments; Potassium; Pulmonary Edema; Renal Insufficiency; Single-Blind Method; Spironolactone; Treatment Outcome | 2014 |
Continuous ultrafiltration for congestive heart failure: the CUORE trial.
Topics: Aged; Aged, 80 and over; Body Weight; Cardiovascular Agents; Confidence Intervals; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Kidney Function Tests; Male; Monitoring, Physiologic; Natriuretic Peptide, Brain; Patient Readmission; Proportional Hazards Models; Severity of Illness Index; Treatment Outcome; Ultrafiltration | 2014 |
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Diuretics; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Injections, Intravenous; Length of Stay; Male; Natriuretic Peptide, Brain; Prospective Studies; Urine; Weight Loss | 2014 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Failure; Humans; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2017 |
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
Topics: Acetazolamide; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Treatment Outcome; Ventricular Function, Left | 2017 |
Diuretics versus volume expansion in acute submassive pulmonary embolism.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Diuretics; Echocardiography, Doppler; Female; Fluid Therapy; France; Furosemide; Humans; Infusions, Intravenous; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pulmonary Embolism; Sodium Chloride; Time Factors; Treatment Outcome; Troponin I; Ventricular Dysfunction, Right; Ventricular Function, Right; Water-Electrolyte Balance | 2017 |
Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
Topics: Aged; Biomarkers; Clinical Deterioration; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Outpatients; Peptide Fragments; Treatment Outcome | 2017 |
Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
Topics: Acute Disease; Aged; Central Venous Pressure; Creatinine; Diuretics; Edema, Cardiac; Equipment and Supplies; Female; Fluid Therapy; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Saline Solution; Urine; Water-Electrolyte Balance | 2019 |
Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
Topics: Administration, Intravenous; Aged; Biomarkers; Diuretics; Double-Blind Method; Drug Resistance; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Kidney Function Tests; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Sodium; Treatment Outcome | 2020 |
Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
Topics: Creatinine; Diuretics; Drug Monitoring; Female; Furosemide; Heart Failure; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Mortality; Natriuretic Peptide, Brain; Outcome and Process Assessment, Health Care; Patient Readmission; Peptide Fragments; Time-to-Treatment; United States | 2021 |
Diuretics Versus Volume Expansion in the Initial Management of Acute Intermediate High-Risk Pulmonary Embolism.
Topics: Acute Disease; Biomarkers; Diuretics; Furosemide; Humans; Natriuretic Peptide, Brain; Pulmonary Embolism; Ventricular Dysfunction, Right | 2022 |
30 other study(ies) available for furosemide and natriuretic peptide, brain
| Article | Year |
|---|---|
HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Cell Line; Cyclic GMP; Furosemide; Glomerular Filtration Rate; Male; Natriuresis; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Peptide Fragments; Polysaccharides; Proteins; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor | 1994 |
How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Topics: Acute Disease; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Diuretics; Epinephrine; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neuropeptide Y; Norepinephrine; Renin; Severity of Illness Index | 1998 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diuretics; Dose-Response Relationship, Drug; Endothelin-1; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radioimmunoassay; Time Factors | 2003 |
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Topics: Animals; Cardiac Output; Cardiac Pacing, Artificial; Cyclic GMP; Diuresis; Diuretics; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Mineralocorticoid Receptor Antagonists; Natriuresis; Natriuretic Peptide, Brain; Norepinephrine; Renal Circulation; Renin-Angiotensin System | 2004 |
Nesiritide for treatment of heart failure due to right ventricular dysfunction.
Topics: Adult; Cardiac Output, Low; Diuretics; Furosemide; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Treatment Outcome; Ventricular Dysfunction, Right; Weight Loss | 2004 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Circulation; Diuretics; Echocardiography; Furosemide; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Kidney; Natriuretic Peptide, Brain; Nitroprusside; Peptide Fragments; Systole; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine | 2006 |
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
Topics: Adult; Body Fluids; Chemokine CCL2; Cytokines; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Hemodiafiltration; Humans; Inflammation Mediators; Interleukin-8; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Retreatment; Treatment Failure; Treatment Outcome | 2007 |
Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Diuretics; Female; Furosemide; Heart Failure; Hemofiltration; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Natriuretic Peptide, Brain; Peritoneal Dialysis | 2010 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Natriuretic Peptide, Brain; Propanolamines; Recurrence; Spironolactone; Vasodilator Agents; Ventricular Dysfunction, Left | 2010 |
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cytokines; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Saline Solution, Hypertonic; Sodium Chloride | 2011 |
Warning on diuretic use.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cohort Studies; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Survival Analysis; Treatment Outcome | 2010 |
Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure.
Topics: Aged; Cardiac Output; Diuretics; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Plasma Volume; Prognosis; Protein Precursors; Retrospective Studies; Sodium; Sodium Chloride, Dietary | 2010 |
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Topics: Acetylglucosaminidase; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Comorbidity; Creatinine; Diuretics; Female; Furosemide; Heart Failure; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney Function Tests; Kidney Tubules; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Receptors, Virus; Renal Insufficiency, Chronic | 2011 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Dyspnea; Etanercept; Female; Furosemide; Glucocorticoids; Hand; Heart Failure; Humans; Immunoglobulin G; Lung Diseases, Interstitial; Natriuretic Peptide, Brain; Propanolamines; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Ribonucleosides; Scleroderma, Systemic; Spironolactone; Sulfasalazine; Tetrazoles; Treatment Outcome | 2011 |
Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insufficiency; Natriuretic Peptide, Brain; Peptide Fragments | 2012 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypernatremia; Kidney Function Tests; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Time Factors; Tolvaptan; Urination | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; Dyspnea; Emergency Service, Hospital; Female; Furosemide; Heart Failure; Humans; Inpatients; Linear Models; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Patient Readmission; Peptide Fragments; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Weight Loss | 2013 |
Passive leg movement enhances diuresis and decline of plasma NT-proBNP level in patients with decompensated heart failure treated with furosemide.
Topics: Biomarkers; Diuresis; Diuretics; Furosemide; Heart Failure; Humans; Leg; Motion Therapy, Continuous Passive; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome; Urination | 2013 |
Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
Topics: Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Proportional Hazards Models; Prospective Studies; Stroke Volume; Systole; Ultrafiltration; Ventricular Function, Left | 2013 |
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; Spironolactone; Time Factors; Treatment Outcome | 2013 |
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cohort Studies; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome | 2014 |
Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Female; Furosemide; Heart Failure; Humans; Lipocalin-2; Lipocalins; Logistic Models; Male; Middle Aged; Natriuretic Peptide, Brain; Odds Ratio; Prognosis; Prospective Studies; Proto-Oncogene Proteins; ROC Curve; Sensitivity and Specificity | 2015 |
Role of Response-to-Diuretic in Predicting Prognosis in Discharged Heart Failure Patients After an Acute Decompensation.
Topics: Aged; Biomarkers; Blood Proteins; Diuretics; Echocardiography; Female; Furosemide; Galectin 3; Galectins; Heart Failure; Hospitalization; Humans; Male; Natriuretic Peptide, Brain; Patient Discharge; Recurrence; Treatment Outcome | 2018 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve Insufficiency; Natriuretic Agents; Natriuretic Peptide, Brain; Pilot Projects | 2019 |
It Is Not Pneumonia! A Case of Unilateral Pulmonary Edema.
Topics: Aged; Diagnosis, Differential; Female; Furosemide; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pulmonary Disease, Chronic Obstructive; Pulmonary Edema; Tachypnea | 2021 |
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR).
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diuretics; Drug Combinations; Female; Furosemide; Glycated Hemoglobin; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Retrospective Studies; Stroke Volume; Turkey; Valsartan; Ventricular Dysfunction, Left | 2021 |
Severe methyl bromide poisoning causing early acute renal failure and anuria: a case report.
Topics: Acute Kidney Injury; Albumins; Animals; Anuria; Dexamethasone; Furosemide; Glutamine; Humans; Hydrocarbons, Brominated; Male; Mice; Middle Aged; Natriuretic Peptide, Brain; Nerve Growth Factors; Protamines; Soil; Sulbactam; Vitamins | 2022 |